Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Total 13F shares
-
901,201
-
Share change
-
+523,122
-
Total reported value
-
$11,887,236
-
Price per share
-
$13.19
-
Number of holders
-
26
-
Value change
-
+$7,837,553
-
Number of buys
-
21
-
Number of sells
-
2
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q1 2015
As of 31 Mar 2015,
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
901,201 shares.
The largest 10 holders included
VANGUARD GROUP INC, AMERICAN INTERNATIONAL GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, PANAGORA ASSET MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, AVIANCE CAPITAL MANAGEMENT, LLC, BlueCrest Capital Management Ltd, and GLENMEDE TRUST CO NA.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.